Genscript Biotech Corporation
GNNSF | OTC
$4.50
+$0.12 (+2.74%)
Nov 2, 2026, 10:19 AM ET · Market open
Fiscal Quarter Period Ending | Q2 2026 Jun 30, 2026 | Q4 2025 Dec 31, 2025 | Q2 2025 Jun 30, 2025 | Q4 2024 Dec 31, 2024 | Q2 2024 Jun 30, 2024 | Q4 2023 Dec 31, 2023 | Q2 2023 Jun 30, 2023 | Q4 2022 Dec 31, 2022 | Q2 2022 Jun 30, 2022 | Q4 2021 Dec 31, 2021 | Q2 2021 Jun 30, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|
PE Ratio | -5.20 | -6.38 | 819.47 | -39.82 | -23.55 | -53.62 | -25.54 | -28.92 | -19.08 | -24.58 | -46.43 |
PEG Ratio | 0.07 | 0 | -4.46 | 0.30 | -0.01 | 0.55 | -12.35 | 0.88 | 0.38 | -0.14 | 12.36 |
PS Ratio | 4.04 | 3.62 | 2.68 | 4.64 | 3.19 | 5.78 | 6.69 | 10.68 | 13.29 | 18.82 | 18.99 |
PB Ratio | 0.88 | 0.88 | 0.50 | 0.64 | 1.92 | 3.49 | 3.49 | 6.62 | 10.01 | 8.82 | 8.53 |
P/FCF Ratio | 67.74 | 14.39 | 11.09 | n/a | -7.17 | -9 | -10.11 | -19.87 | -25.16 | -34.17 | -34.45 |
P/OCF Ratio | 22.78 | 10.68 | 9.56 | n/a | -117.53 | -16.92 | -19.27 | -55.58 | -46.51 | -67.41 | -73.19 |
OCF/S Ratio | 14.06 | 21.08 | 44.84 | n/a | 28 | -22.25 | -47.83 | -18.44 | -20.03 | -38.74 | -15.62 |
Debt / Equity Ratio | 0.07 | 0.07 | 0.12 | 0.17 | 0.81 | 0.30 | 0.28 | 0.35 | 0.30 | 0.15 | 0.06 |
Quick Ratio | 1.42 | 1.41 | 1.90 | 2.62 | 4.06 | 4.65 | 5.52 | 3.12 | 2.82 | 3.86 | 3.17 |
Current Ratio | 1.48 | 1.47 | 1.96 | 2.72 | 4.15 | 4.76 | 5.64 | 3.23 | 2.92 | 3.97 | 3.26 |
Asset Turnover | 0.08 | 0.09 | 0.10 | 0.06 | 0.09 | 0.13 | 0.12 | 0.12 | 0.14 | 0.12 | 0.12 |
Interest Coverage | 7.75 | 9.39 | n/a | 0.04 | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Return on Equity | -3.32% | -12.82% | -0.58% | 72.60% | -14.41% | -0.14% | -6.91% | -9.04% | -17.89% | -25.58% | -9.01% |
Return on Assets | -2.70% | -10.46% | -0.47% | 59.43% | -5.26% | -0.06% | -2.77% | -3.59% | -6.32% | -11.98% | -4.83% |
Return on Invested Capital | 1.16% | 1.65% | 3.58% | 0.01% | 0.31% | -6.53% | -7.89% | -13% | -11.04% | -12.58% | -10.37% |
Dividend Yield | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
FCF Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit Margin | 51.14% | 52.77% | 61.81% | 44.81% | 46.82% | 52.32% | 44.73% | 42.89% | 54.43% | 55.23% | 60.38% |
Net Profit Margin | -32% | -115.11% | -4.91% | 1.01K% | -61.41% | -0.42% | -23.91% | -28.90% | -43.77% | -102.71% | -39.69% |
Pretax Profit Margin | -29.54% | -106.73% | -0.02% | -13.86% | -44.86% | -23.72% | -62.52% | -63.87% | -74.22% | -140.92% | -65.44% |
Operating Profit Margin | 12.26% | 17.28% | 34.52% | 0.11% | 3.14% | -43.11% | -56.88% | -82.49% | -57.25% | -87.12% | -66.35% |
FCF Margin | 2.26% | 9.35% | 38.65% | n/a | -19% | -60.68% | -68.33% | -63.42% | -43.90% | -63.42% | -45.57% |
EBITDA Margin | 22.26% | 24.66% | 40.27% | 9.13% | 14.65% | -36.65% | -49.64% | -74.70% | -49.34% | -80.40% | -57.55% |
Add to Watchlist
Select watchlists to add or remove GNNSF